Table III. —Results of pain and functionality scores of patients: night pain.
| Variables | hrESWT | mrESWT | prESWT | P* | η2 | Post-hoc PC | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean±SD | Mean±SD | Mean±SD | |||||||||
| Night pain (0-10 cm) |
Baseline | 8.23±1.59 | 8.81±0.99 | 7.88±1.23 | 0.199 | 0.09 | |||||
| After treatment | 4.42±2.1 | 3.54±2.15 | 5.88±1.61 | 0.015 | 0.21 | 2-3 (P=0.022) | |||||
| Mean change (95% CI) | -3.81±2.19 (-5.13; -2.48) |
-5.27±2.37 (-6.70; -3.84) |
-2.01±2.19 (-3.33; -0.69) |
0.003 | 0.27 | 2-3 (P=0.002) | |||||
| Effect size | pp | -1.74 | P<0.001 | -2.22 | P<0.001 | -0.92 | P=0.006 | ||||
Data shown are mean±standard deviation and 95% CI values for variables. Statistically significance: P˂0.005. Models Test: 1 (hrESWT); 2 (mrESWT); 3 (prESWT); 1-3 (hrESWT statistically different from prESWT); 2-3 (mrESWT statistically different from prESWT). hrESWT: High-energy radial extracorporeal shock wave therapy (0.25 mj/mm2); mrESWT: medium-energy radial extracorporeal shock wave therapy (0.12 mj/mm2); prESWT: placebo radial extracorporeal shock wave therapy (0.0 mj/mm2); 0: no pain; 10: worst imaginable pain; η2: partial eta squared; PC: pairwise comparison. ^Significance level of paired sample t-test; *significance level of general linear mixed model test.